Medpace Holdings (MEDP) Short term Debt (2015 - 2023)

Medpace Holdings' (MEDP) quarterly Short term Debt came in at $55.0 million in Q2 2023, down 77.97% YoY from $249.7 million in Q2 2022, and down 52.17% on a QoQ basis from $115.0 million in Q1 2023.

Medpace Holdings (MEDP) Short term Debt (2015 - 2023) Analysis & Trends

Medpace Holdings (MEDP) has 6 years of Short term Debt data on file, last reported at $55.0 million in Q2 2023.

  • Quarterly Short term Debt fell 77.97% year-over-year to $55.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $55.0 million (down 77.97% YoY) and the FY2022 annual result came in at $50.0 million, changed N/A from the prior year.
  • Short term Debt slipped to $55.0 million in Q2 2023, from $115.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $249.7 million in Q2 2022 to a low of $50.0 million in Q4 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Medpace Holdings 16.54 Bn 16.03 Bn 201.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 55.00 Mn
Mar 31, 2023 115.00 Mn
Dec 31, 2022 50.00 Mn
Sep 30, 2022 139.70 Mn
Jun 30, 2022 249.70 Mn
Jun 30, 2018 16.50 Mn
Mar 31, 2018 16.50 Mn
Dec 31, 2017 16.50 Mn
Sep 30, 2017 15.47 Mn
Jun 30, 2017 14.44 Mn
Mar 31, 2017 13.41 Mn
Dec 31, 2016 12.38 Mn
Dec 31, 2015 59,000.00